Kumar A - Search Results

1

Early intravenous unfractionated heparin and mortality in septic shock.

Zarychanski R, Doucette S, Fergusson D, Roberts D, Houston DS, Sharma S, Gulati H, Kumar A. Zarychanski R, et al. Among authors: kumar a. Crit Care Med. 2008 Nov;36(11):2973-9. doi: 10.1097/CCM.0b013e31818b8c6b. Crit Care Med. 2008. PMID: 18824906

2

Cytokine modulation in sepsis and septic shock.

Zanotti S, Kumar A, Kumar A. Zanotti S, et al. Among authors: kumar a. Expert Opin Investig Drugs. 2002 Aug;11(8):1061-75. doi: 10.1517/13543784.11.8.1061. Expert Opin Investig Drugs. 2002. PMID: 12150702 Review.

3

Clinical review: Myocardial depression in sepsis and septic shock.

Court O, Kumar A, Parrillo JE, Kumar A. Court O, et al. Among authors: kumar a. Crit Care. 2002 Dec;6(6):500-8. doi: 10.1186/cc1822. Epub 2002 Sep 12. Crit Care. 2002. PMID: 12493071 Free PMC article. Review.

4

Circulating substances and energy metabolism in septic shock.

Kumar A, Wood K, Parrillo JE. Kumar A, et al. Crit Care Med. 2003 Feb;31(2):632-3. doi: 10.1097/01.CCM.0000050073.36518.A2. Crit Care Med. 2003. PMID: 12576976 No abstract available.

5

Septic shock, multiple organ failure, and acute respiratory distress syndrome.

Sharma S, Kumar A. Sharma S, et al. Among authors: kumar a. Curr Opin Pulm Med. 2003 May;9(3):199-209. doi: 10.1097/00063198-200305000-00008. Curr Opin Pulm Med. 2003. PMID: 12682565 Review.

6

Interleukin-10 blunts the human inflammatory response to lipopolysaccharide without affecting the cardiovascular response.

Kumar A, Zanotti S, Bunnell G, Habet K, Añel R, Neumann A, Cheang M, Dinarello CA, Cutler D, Parrillo JE. Kumar A, et al. Crit Care Med. 2005 Feb;33(2):331-40. doi: 10.1097/01.ccm.0000152229.69180.2. Crit Care Med. 2005. PMID: 15699836 Clinical Trial.

7

Human endotoxemia and human sepsis: limits to the model.

Anel R, Kumar A. Anel R, et al. Among authors: kumar a. Crit Care. 2005 Apr;9(2):151-2. doi: 10.1186/cc3501. Epub 2005 Mar 4. Crit Care. 2005. PMID: 15774069 Free PMC article.

8

Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.

Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M. Kumar A, et al. Crit Care Med. 2006 Jun;34(6):1589-96. doi: 10.1097/01.CCM.0000217961.75225.E9. Crit Care Med. 2006. PMID: 16625125

9

Transforming growth factor-beta1 blocks in vitro cardiac myocyte depression induced by tumor necrosis factor-alpha, interleukin-1beta, and human septic shock serum.

Kumar A, Kumar A, Paladugu B, Mensing J, Parrillo JE. Kumar A, et al. Crit Care Med. 2007 Feb;35(2):358-64. doi: 10.1097/01.CCM.0000254341.87098.A4. Crit Care Med. 2007. PMID: 17204997

10

Antibiotic management of suspected nosocomial ICU-acquired infection: does prolonged empiric therapy improve outcome?

Aarts MA, Brun-Buisson C, Cook DJ, Kumar A, Opal S, Rocker G, Smith T, Vincent JL, Marshall JC. Aarts MA, et al. Among authors: kumar a. Intensive Care Med. 2007 Aug;33(8):1369-78. doi: 10.1007/s00134-007-0723-y. Epub 2007 Jun 9. Intensive Care Med. 2007. PMID: 17558493

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31,608 results

Search Page

Filters